Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

RCBTB1 Deletion Is Associated with Metastatic Outcome and Contributes to Docetaxel Resistance in Nontranslocation-Related Pleomorphic Sarcomas.

Cancers·2019

Same author

Pseudomyxoma Peritonei: A Case Report Diagnosed in a 47-Year-Old Woman with Chronic Pelvic Abdominal Pain and Appendicular Origin: Review of the Literature and Management.

Frontiers in surgery·2018

Same author

Genome profiling is an efficient tool to avoid the STUMP classification of uterine smooth muscle lesions: a comprehensive array-genomic hybridization analysis of 77 tumors.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2018

Same author

Paravertebral Well-Differentiated Liposarcoma with Low-Grade Osteosarcomatous Component: Case Report with 11-Year Follow-Up, Radiological, Pathological, and Genetic Data, and Literature Review.

Case reports in pathology·2017

Same author

Drug-induced aortic valve stenosis: An under recognized entity.

International journal of cardiology·2016

Same author

Gene Expression Profiling of Desmoid Tumors by cDNA Microarrays and Correlation with Progression-Free Survival.

Clinical cancer research : an official journal of the American Association for Cancer Research·2015

Search research articles

Related Experiment Video

Updated: Jun 15, 2026

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

Soft tissue sarcomas with complex genomic profiles.

Louis Guillou¹, Alain Aurias

¹University Institute of Pathology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Rue du Bugnon 25, Lausanne, Switzerland. louis.guillou@chuv.ch

Virchows Archiv : an International Journal of Pathology

|March 11, 2010

Summary

Soft tissue sarcomas (STS) with complex genomic profiles often show chromosomal gains and losses. Understanding these genomic alterations is crucial for diagnosing and treating these challenging spindle cell neoplasms.

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on: August 25, 2023

Related Experiment Videos

Last Updated: Jun 15, 2026

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on: August 25, 2023

Area of Science:

Oncology
Genetics
Pathology

Background:

Soft tissue sarcomas (STS) encompass diverse neoplasms, with 50% exhibiting complex genomic profiles.
These complex STS are often spindle cell or pleomorphic sarcomas, including leiomyosarcoma and malignant peripheral nerve sheath tumors.
Genomic complexity in STS is characterized by numerous chromosomal gains, losses, and amplifications.

Purpose of the Study:

To review the cytogenetic, molecular genetic, and clinicopathologic features of common STS with complex genomic profiles.
To discuss diagnostic and prognostic features of these sarcomas.
To highlight recurrent genomic aberrations and their role in tumor progression and metastasis.

Main Methods:

Literature review of cytogenetic, molecular genetic, and clinicopathologic studies.
Analysis of genomic aberrations, including chromosomal gains, losses, and amplifications.
Correlation of genomic findings with tumor characteristics and clinical outcomes.

Main Results:

Complex genomic profiles are characteristic of many STS, particularly spindle cell/pleomorphic types.
Recurrent genomic aberrations, such as gain of 5p13-p15, are observed and implicated in tumor progression.
Specific STS subtypes display distinct, yet complex, genomic alterations.

Conclusions:

Complex genomic profiles are a hallmark of a significant subset of soft tissue sarcomas.
Understanding these genomic alterations is essential for accurate diagnosis and prognosis.
Further research into recurrent aberrations may reveal therapeutic targets for STS.